Pharma

pause halt pause button
Biotech

Daiichi-Merck ph. 3 ADC program on pause after patient deaths

Daiichi and Merck’s phase 3 program for I-DXd has been hit with a hold after an unexpected number of deaths occurred.
Gabrielle Masson Dec 18, 2025 11:22am
helicopter rescue mission save aircraft

Athira inks deal to power ex-Pfizer asset toward phase 3 data

Dec 18, 2025 10:56am
Yellow tape measure with a variety of weight loss medication on blue background

Lilly's obesity pill maintains weight lost on injectable GLP-1s

Dec 18, 2025 8:20am
base camp tent mountain summit

GSK pays $17.5M for CAMP4 regulatory RNA deal

Dec 18, 2025 7:00am
graphic image of different colored hands shaking

Vir links up with Norgine in €550M hepatitis D licensing deal

Dec 17, 2025 12:50pm
data error magnifying glass inspection mistake

Nektar claims ph. 2 alopecia success after excluding 4 patients

Dec 16, 2025 5:05pm